Cormorant Asset Management, LP

13F Holdings History for VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE)

Symbol: VYNE on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 1.37M shares
Security Ownership: 8.23%

Shares, Excluding Options vs Price

Value, Excluding Options

Cormorant Asset Management, LP ownership in VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share (VYNE)

2025-08-14 - Cormorant Asset Management, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.37M shares of VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share (VYNE). This represents 8.23% percent ownership of the company. In their previous filing dated 2025-05-19, Cormorant Asset Management, LP had reported owning 1.85M shares, indicating a decrease of -25.9% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Cormorant Asset Management, LP	8.23%	-17.6%	$439K	1.37M	-478,652	-25.9%	$0.32	13G/A	6/30/2025	14 Aug 2025 15:04:01
Cormorant Asset Management, LP	9.99%		$3.48M	1.85M			$1.88	13G/A	3/31/2025	19 May 2025 17:47:42
Cormorant Asset Management, LP	0%			0			$1.48	13G/A	3/31/2025	15 May 2025 15:03:10

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.17%	+0.17%	$2.26M	1.37M	+1,370,938	NEW	$1.65	Q2 2025
3/31/2025		-0.26%	$0	0	-1,394,336	-100%		Q1 2025
12/31/2024	0.26%		$4.67M	1.39M			$3.35	Q4 2024
9/30/2024	0.14%		$2.62M	1.39M			$1.88	Q3 2024
6/30/2024	0.16%		$2.75M	1.39M			$1.97	Q2 2024
3/31/2024	0.19%		$4.28M	1.39M			$3.07	Q1 2024
12/31/2023	0.16%	+0.19%	$3.25M	1.39M	+1,394,336	NEW	$2.33	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.